| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T436-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2405-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2405-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6848
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-92 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N30-72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N27-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-92 |
| filingDate |
2008-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2010-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2010534826-A |
| titleOfInvention |
Methods for diagnosing, assessing risk and monitoring autism spectrum disorders |
| abstract |
A method for diagnosing, risk assessment, and monitoring of Autism Spectrum Disorder (ASD) is disclosed. More specifically, the present invention relates to small molecules (metabolites) in human plasma that have been found to differ in abundance between individuals with clinical symptoms of ASD and subjects who do not exhibit symptoms of ASD. Regarding measurement. Furthermore, the present invention relates to the monitoring of putative therapeutic strategies aimed at ameliorating biochemical abnormalities associated with ASD. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102550459-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016530504-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20210089209-A |
| priorityDate |
2007-07-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |